Dec 23, 2022 UK Supreme Court to assess plausibility of anaemia patents By Heidi Hurdle The UK Supreme Court has just confirmed that it will hear the appeal in FibroGen Inc v Akebia Therapeutics concerning patents for...
Nov 03, 2022 The Second Draft Patent Examination Guidelines on Patent Linkage Invalidation, PTE and PTA By Alison Wong Martoe Xu TTThe second draft amendment to the Patent Examination Guidelines (the “Second Draft”) was issued by the China National Intellectual...
Sep 16, 2022 The Pharmaceutical Intellectual Property and Competition Law Review By Sally Shorthose Christopher de Mauny Pieter Erasmus Peter Willis +1 more... Show less The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property...
Sep 07, 2022 China’s First Supreme Court Patent Linkage Decision By Alison Wong Martoe Xu On 5 August 2022, the Chinese Supreme Court (the “SPC”) handed down the second instance judgment on Chugai Pharmaceutical Co.,Ltd (the...
Jul 18, 2022 Final(ly) Rules of Procedure of the UPC By Christopher de Mauny Domien Op de Beeck Apart from the Unified Patent Court Agreement and a large body of further treaties, regulations, directives and laws governing the...
May 19, 2022 New Draft Implementing Regulations propose key changes for pharmaceuticals in China By Alison Wong Martoe Xu On 9 May 2022, the National Medical Products Administration (the “NMPA”) published the Implementing Regulations of the Drug...
Apr 07, 2022 The UPC Committees rule! By Wouter Pors Start of the Provisional Application Phase and first committee meetings The Provisional Application Phase of the Unified Patent Court...